Hematologic Neoplasms: all 1,494 studies
Page 15 of 15. Open to participants first (438), then studies with results posted, then the rest; newest registration first within each.
- Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)CompletedNCT00557817Phase 2/3
- Lipid Use, Nutrition, and Colitis in Patients With Hematological MalignanciesCompletedNCT00533078Phase 2
- Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer PatientsCompletedNCT00526045Phase 1/2
- Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHDStatus unknownNCT00524784Phase 1/2
- Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic MalignanciesCompletedNCT00521859Phase 1
- Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic MalignanciesTerminatedNCT00514722Not applicable
- Adult Double Cord Blood Transplant StudyCompletedNCT00514579Phase 2
- Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic MalignanciesTerminatedNCT00513318
- Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic AnemiaCompletedNCT00513175
- Collection of Outcomes Data for Pregnant Patients With CancerTerminatedNCT00507572
- A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic MalignanciesCompletedNCT00506402Phase 1
- Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host DiseaseCompletedNCT00504803Phase 2
- A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCTCompletedNCT00477542Phase 1
- Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic MalignanciesCompletedNCT00477035Phase 1
- Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic TransplantCompletedNCT00476177Phase 1
- Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer PatientsCompletedNCT00473577Phase 1
- A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589CompletedNCT00472368Phase 1
- Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative TherapyCompletedNCT00469729Phase 2/3
- Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological MalignanciesCompletedNCT00460694Phase 1/2
- VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the NetherlandsCompletedNCT00440765
- ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.CompletedNCT00440479
- Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological MalignanciesCompletedNCT00438178Phase 1
- Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic MalignanciesCompletedNCT00430846Phase 1
- Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological MalignanciesCompletedNCT00423124Phase 1/2
- Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow CancersTerminatedNCT00421213Phase 2
- Pegfilgrastim Versus Filgrastim After High-dose ChemotherapyCompletedNCT00410696Phase 2
- A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic MalignanciesCompletedNCT00405743Phase 1/2
- Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.CompletedNCT00389428Phase 1
- Nonmyeloablative Stem Cell Transplant in ElderlyCompletedNCT00382759Phase 2/3
- Low Bacterial Diet in Patients With CytopeniaCompletedNCT00367588Not applicable
- Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell TransplantationCompletedNCT00355407Not applicable
- An Evaluation of the Effect of 'Open Window' on Psychological Well-being and Experience of Stem Cell TransplantationCompletedNCT00348959Not applicable
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic MalignanciesCompletedNCT00343798Phase 1
- CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell TransplantationCompletedNCT00333190Not applicable
- Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood TransplantationStatus unknownNCT00328237Phase 2
- Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or CancerCompletedNCT00312429Phase 1/2
- Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient OutcomesStatus unknownNCT00300001
- Trial of AVN-944 in Patients With Advanced Hematologic MalignanciesCompletedNCT00273936Phase 1
- Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic MalignanciesCompletedNCT00270881Phase 1/2
- Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic MalignanciesCompletedNCT00246662Phase 1
- A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)CompletedNCT00230321Phase 1/2
- Allogeneic Cell Therapy for Adults With Hematologic MalignanciesCompletedNCT00208962Phase 2
- Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic MalignanciesCompletedNCT00208923Phase 2
- Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic MalignanciesCompletedNCT00202917Phase 1/2
- Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic PatientsCompletedNCT00195533
- Haploidentical Stem Cell Transplantation for Patients With Hematologic MalignanciesCompletedNCT00186823Phase 3
- Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic MalignanciesCompletedNCT00186342Not applicable
- Stem Cell Transplant From Matched Unrelated or Partially Matched Related DonorsCompletedNCT00186225Not applicable
- TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPDCompletedNCT00185796Phase 2
- Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])CompletedNCT00179764Not applicable
- Mindfulness Meditation in Bone Marrow TransplantationCompletedNCT00165282Phase 2/3
- RCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMTStatus unknownNCT00163644Not applicable
- Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in IsraelCompletedNCT00159003
- Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic StudyStatus unknownNCT00156858Not applicable
- Stem Cell Transplantation for Patients With Hematologic MalignanciesCompletedNCT00152139Phase 3
- Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the HostWithdrawnNCT00149032Phase 2
- Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell TransplantationCompletedNCT00146614Phase 2
- Haploidentical Stem Cell Transplant for Treatment Refractory Hematological MalignanciesCompletedNCT00145613Phase 2
- Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell TransplantationCompletedNCT00144703Phase 2
- Stem Cell Transplantation as Immunotherapy for Hematologic MalignanciesCompletedNCT00143559Phase 2
- Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell TransplantationCompletedNCT00138112Phase 3
- MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological MalignanciesStatus unknownNCT00129155Phase 2
- Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic MalignanciesTerminatedNCT00113828Phase 2
- Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic MalignanciesTerminatedNCT00113646Phase 2
- Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic MalignanciesTerminatedNCT00113048Phase 1
- STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid TumorsCompletedNCT00088101Phase 1
- Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)CompletedNCT00086125Phase 2
- OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic MalignanciesWithdrawnNCT00081055Phase 2
- T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic MalignanciesCompletedNCT00080925Phase 1
- Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantCompletedNCT00078858Phase 1/2
- 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic MalignanciesCompletedNCT00077181Phase 1
- VNP40101M and Cytarabine in Treating Patients With Hematologic MalignanciesCompletedNCT00070538Phase 1
- Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic MalignanciesTerminatedNCT00070239Phase 1
- Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic MalignanciesCompletedNCT00068523Not applicable
- A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow TransplantationCompletedNCT00067730Phase 4
- Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic MalignanciesCompletedNCT00061620Phase 1
- Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological DiseasesCompletedNCT00056966Phase 1/2
- A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic MalignanciesCompletedNCT00051597Phase 1/2
- Study of ABT-751 in Patients With Refractory Hematologic MalignanciesCompletedNCT00047489Phase 1
- Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or LymphomaCompletedNCT00044759Phase 3
- IUdR/BUdR Cell Cycle LabellingCompletedNCT00042250Not applicable
- Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose ChemotherapyCompletedNCT00041665Phase 3
- Phase II Study Of Roferon and Accutane For Patients With T-Cell MalignanciesCompletedNCT00038376Phase 2
- Clofarabine in Chronic Lymphocytic LeukemiaCompletedNCT00028418Phase 1
- Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerCompletedNCT00027820Phase 1/2
- Non-Ablative Allo HSCT For Hematologic Malignancies or SAACompletedNCT00006379Phase 2
- Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerCompletedNCT00005799Not applicable
- Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood CancerCompletedNCT00005785Phase 1
- Arsenic Trioxide in Treating Patients With Advanced Hematologic CancerCompletedNCT00003395Phase 1
- The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood CancersCompletedNCT00001873Phase 2
- Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-DiseaseCompletedNCT00001872
- HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological MalignanciesCompletedNCT00001748Phase 1
- Bone Marrow Transplant Studies for Safe and Effective Treatment of LeukemiaCompletedNCT00001623Not applicable
- The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic MalignanciesCompletedNCT00001432